Showing results (2011-2020 of 2,369) with videos related to
Sort By:
Pageof 237
Critical Reviews in Oncology/Hematology|December 10, 2013
Salvage therapy of small volume prostate cancer nodal failures: a review of the literatureBerardino De Bari, Filippo Alongi, Michela Buglione, et al.Cancers|April 13, 2023
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage TreatmentLorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, et al.European Urology Oncology|May 3, 2022
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial CarcinomaAlberto Martini, Chiara Lonati, Luigi Nocera, et al.BJU International|March 5, 2016
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional studyRomain Mathieu, Ilaria Lucca, Mihai D Vartolomei, et al.The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.Translational Andrology and Urology|March 21, 2025
DNA methylation alterations in prostate cancer: from diagnosis to treatmentFrancesco Barletta, Marco Bandini, Giuseppe Ottone Cirulli, et al.Cancers|January 8, 2023
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or RecurrenceLorenzo Bianchi, Francesco Ceci, Francesco Costa, et al.International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.Pageof 237